Molecular characterization of a local sulfonylurea system in human adipose tissue

Molecular and Cellular Biochemistry

Volumn 258, Issue 1-2, 2004, Pages 65-71

  Gabrielsson, Britt G ^a   Karlsson, A Cecilia ^a   Lönn, Malin ^a   Olofsson, Louise E ^a   Johansson, Jenny M ^a   Torgerson, Jarl S ^a   Sjöström, Lars ^a   Carlsson, Björn ^a   Edén, Staffan ^a   Carlsson, Lena M S ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adipose tissue depots; Human; Obesity; Sulfonylurea receptor 2; Weight reduction

Indexed keywords

ADENOSINE TRIPHOSPHATE; DNA; ENDOSULFAN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ISOPROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROTEIN SUBUNIT; SULFONYLUREA; SULFONYLUREA RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BIOPSY; CELL MEMBRANE POTENTIAL; CELL METABOLISM; CONTROLLED STUDY; DNA SEQUENCE; DRUG RECEPTOR BINDING; DRUG TARGETING; FOOD INTAKE; FOOD PREFERENCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HEART; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.1; LIVER; LOW CALORY DIET; MALE; PANCREAS; PERITONEUM; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN TARGETING; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION; WEIGHT REDUCTION;

ADIPOSE TISSUE; ATP-BINDING CASSETTE TRANSPORTERS; DIET THERAPY; FEMALE; HUMANS; MIDDLE AGED; OBESITY; PEPTIDES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; WEIGHT LOSS;

EID: 1442330881     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000012837.11847.c8     Document Type: Article

References (23)

1. Gabrielsson BL, Carlsson B, Carlsson LM: Partial genome scale analysis of gene expression in human adipose tissue using DNA array. Obes Res 8: 374-384, 2000
2. Shi H, Moustaid-Moussa N, Wilkison WO, Zemel MB: Role of the sulfonylurea receptor in regulating human adipocyte metabolism. FASEB J 13: 1833-1838, 1999
3. Babenko AP, Aguilar-Bryan L, Bryan J: A view of SUR/KIR6.X, KATP channels. Annu Rev Physiol 60: 667-687, 1998
4. + channels. Trends Neurosci 21: 288-294, 1998
5. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 274: C25-C37, 1998
6. Aguilar-Bryan L, Clement JP, Gonzalez G, Kunjilwar K, Babenko A, Bryan J: Toward understanding the assembly and structure of KATP channels. Physiol Rev 78: 227-245, 1998
7. Chutkow WA, Makielski JC, Nelson DJ, Burant CF, Fan Z: Alternative splicing of SUR2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J Biol Chem 274: 13656-13665, 1999
8. Chutkow WA, Simon MC, Le Beau MM, Burant CF: Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes 45: 1439-1445, 1996
9. Inagaki N, Gonoi T, Clement JP, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J: Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166-1170, 1995
10. Inagaki N, Inazawa J, Seino S: cDNA sequence, gene structure, and chromosomal localization of the human ATP-sensitive potassium channel, uKATP-1, gene (KCNJ8). Genomics 30: 102-104, 1995
11. + channels. Neuron 16: 1011-1017, 1996
12. + channel. J Biol Chem 271: 24321-24324, 1996
13. Pfeifer MA, Halter JB, Graf R, Porte D Jr: Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide. Diabetes 29: 335-340, 1980
14. 2+ concentration in isolated rat adipocytes. Diabetes 36: 174-178, 1987
15. 2+-dependent mechanism. FASEB J 12: 1391-1396, 1998
16. Heron L, Virsolvy A, Peyrollier K, Gribble FM, Le Cam A, Ashcroft FM, Bataille D: Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: Molecular cloning, expression and biological properties. Proc Natl Acad Sci USA 95: 8387-8391, 1998
17. Smith U, Sjöström L, Björntorp P: Comparison of two methods for determining human adipose cell size. J Lipid Res 13: 822-824, 1972
18. Russ U, Hambrock A, Artunc F, Loffler-Walz C, Horio Y, Kurachi Y, Quast U: Coexpression with the inward rectifier K(+) channel kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide. Mol Pharmacol 56: 955-961, 1999
19. Bolinder J, Kager L, Östman J, Arner P: Differences at the receptor and postreceptor level, between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32: 117-123, 1983
20. Zierath JR, Livingston JN, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P: Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: Relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia 41: 1343-1354, 1998
21. Katoh S, Shoici H, Matsushima M, Ikemoto S, Inoue Y, Yokoyama J, Tajima N: Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy - a randomized controlled trial. Metabolism 50: 414-417, 2000
22. Alemzadeh R, Langley G, Upchurch L, Smith P, Slonim AE: Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 83: 1911-1915, 1998
23. Miura H, Wachtel RE, Loberiza FR Jr, Saito T, Miura M, Nicolosi AC, Gutterman DD: Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: Reduced activity of ATP-sensitive potassium channels. Circ Res 92: 151-158, 2003